Who invested in Sensorium Therapeutics?
Sensorium Therapeutics's investors include Hatteras Venture Partners and Mission BioCapital.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$25Mraised across 1 round since 2025, from 1 source
Source recordedSEC filing: $27M sold, first sale Jan 2025
Sensorium Therapeutics's investors include Hatteras Venture Partners and Mission BioCapital.
Sensorium Therapeutics has raised $25M across 1 round since 2025.
Sensorium Therapeutics's most recent round was a Series A of $25M in Aug 2025.
Its most recent round, $25M in Aug 2025, is also its largest on record.
Sensorium Therapeutics's first round on record, in Aug 2025, was backed by Hatteras Venture Partners and Mission BioCapital.
Sensorium Therapeutics's latest named round is a Series A, in Aug 2025.
Sensorium Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.